A study group of the European Society of Cutaneous Lupus Erythematosus (EUSCLE) developed a Core Set Questionnaire for the evaluation of patients with cutaneous lupus erythematosus (CLE). The aim of the EUSCLE Core Set Questionnaire is to gain a broad and comparable data collection of patients with CLE from different European centers, to achieve consensus concerning evidence-based clinical standards for disease assessment, and to develop diagnostic and therapeutic guidelines. The authors designed the EUSCLE Core Set Questionnaire by including parameters considered most relevant for the evaluation of CLE and compiled from international literature, clinical praxis, and long-term experience with this disease. The compilation of the different p...
BackgroundSystemic lupus erythematosus (SLE) can manifest with arthralgia and myalgia, and in severe...
Background Systemic lupus erythematosus (SLE) can manifest with arthralgia and myalgia, and, in s...
Objectives To develop recommendations for monitoring patients with systemic lupus erythematosus (SLE...
Abstract A study group of the European Society of Cutaneous Lupus Erythematosus (EUSCLE) develope...
Cutaneous lupus erythematosus (CLE) is a clinically heterogeneous group of rare skin dis-eases that ...
There is currently no uniform definition of cutaneous lupus erythematosus (CLE) upon which to base a...
OBJECTIVE: The diagnosis and treatment of the mucocutaneous (MC), neuropsychiatric (NP), and renal (...
We developed and validated a measurement instrument (CLASI—Cutaneous Lupus Erythematosus Disease Are...
Background The Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) is a scoring s...
OBJECTIVE: To identify preliminary core sets of outcome variables for disease activity and damage as...
Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with wide clinical fe...
Introduction: The Systemic Lupus Erythematosus Activity Questionnaire (SLAQ) is a patient-reported i...
Objective: Systemic lupus erythematosus (SLE) is a complex multi-organ disease, characterised by rel...
OBJECTIVE: Systemic lupus erythematosus (SLE) is a complex disease with variable presentations, cour...
BackgroundSystemic lupus erythematosus (SLE) can manifest with arthralgia and myalgia, and in severe...
Background Systemic lupus erythematosus (SLE) can manifest with arthralgia and myalgia, and, in s...
Objectives To develop recommendations for monitoring patients with systemic lupus erythematosus (SLE...
Abstract A study group of the European Society of Cutaneous Lupus Erythematosus (EUSCLE) develope...
Cutaneous lupus erythematosus (CLE) is a clinically heterogeneous group of rare skin dis-eases that ...
There is currently no uniform definition of cutaneous lupus erythematosus (CLE) upon which to base a...
OBJECTIVE: The diagnosis and treatment of the mucocutaneous (MC), neuropsychiatric (NP), and renal (...
We developed and validated a measurement instrument (CLASI—Cutaneous Lupus Erythematosus Disease Are...
Background The Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) is a scoring s...
OBJECTIVE: To identify preliminary core sets of outcome variables for disease activity and damage as...
Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with wide clinical fe...
Introduction: The Systemic Lupus Erythematosus Activity Questionnaire (SLAQ) is a patient-reported i...
Objective: Systemic lupus erythematosus (SLE) is a complex multi-organ disease, characterised by rel...
OBJECTIVE: Systemic lupus erythematosus (SLE) is a complex disease with variable presentations, cour...
BackgroundSystemic lupus erythematosus (SLE) can manifest with arthralgia and myalgia, and in severe...
Background Systemic lupus erythematosus (SLE) can manifest with arthralgia and myalgia, and, in s...
Objectives To develop recommendations for monitoring patients with systemic lupus erythematosus (SLE...